Risk management advisory committee plays it safe
Executive Summary
FDA postpones Drug Safety & Risk Management Advisory Committee Sept. 18 and 19 meeting as a result of Hurricane Isabel. Committee was slated to discuss labeling and packaging of drug products in low-density polyethylene plastic vials Sept. 18 and screening methods for look-alike, sound-alike proprietary drug names Sept. 19 (1"The Pink Sheet" June 29, 2003, In Brief)...
You may also be interested in...
Sound-alike, look-alike drug names
FDA Drug Safety & Risk Assessment Advisory Committee will discuss current screening methods for sound-alike and look-alike proprietary drug names Sept. 19. The meeting will take place at the Holiday Inn in Silver Spring, Md. at 8 a.m. [Editor's note: To sign up for a webcast or video of this meeting, go to FDAAdvisoryCommittee.com]...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.